NCT06205602: An ongoing trial by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
This trial is ongoing. It must report results 4 years, 2 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06205602 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled Study of the Combination of Two Long-Acting Broadly Neutralizing Antibodies at ART Initiation in Adults Living With HIV-1 in Sub-Saharan Africa: The ACACIA Study |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 17, 2025 |
| Completion date | Feb. 16, 2029 |
| Required reporting date | Feb. 16, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |